Search

everythinglearnresearchcommunity

for

Search:↓

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.